Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease Based on the 12-Item Short Form Survey.
Tran B LockeAuddie M SweisJennifer E DouglasKevin I Ig-IzevbekhaiElizabeth M StevensAlyssa M CivantosElizabeth B McCartyAnkur KumarMichael A KohanskiDavid W KennedyJames N PalmerJohn V BossoNithin D AdappaPublished in: American journal of rhinology & allergy (2021)
AERD patients undergoing ESS and ATAD show improvement in physical QOL and 3 of the 8 health domains as measured by the SF-12. Future studies can use the SF-12 to study the impact of AERD treatment versus other chronic diseases and health demographics.